Prognostic role of cyclin d1 in lung cancer relationship to proliferating cell nuclear antigen

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 4, 1999, Pages 746-750

  Caputi, Mario ^b   Groeger, Angela M ^b   Esposito, Vincenzo ^b   Dean, Charity ^b   De Luca, Antonio ^b   Pacilio, Carmen ^b   Muller, Michael R ^b   Giordano, Giovan G ^b   Baldi, Feliciano ^b   Wolner, Ernst ^b   Giordano, Antonio ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLINE;

ADENOCARCINOMA; ARTICLE; CANCER STAGING; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; MORTALITY; PATHOLOGY; PROGNOSIS; PROTEIN SYNTHESIS; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADENOCARCINOMA; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CYCLIN D1; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BIOSYNTHESIS; SURVIVAL ANALYSIS; TRANSCRIPTION, GENETIC;

EID: 0033111210     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.4.3366     Document Type: Article

References (31)

1. MacLachlan, T. K., N. Sang, and A. Giordano. 1995. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control. Crit. Rev. Eukaryot. Gene Expr. 5:127-156.
2. Motokura, T., and A. Arnold. 1993. Cyclins and oncogenesis. Biochim. Biophys. Acta 1155:63-78.
3. Lammie, G. A., and G. Peters. 1991. Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3:413-420.
4. Keyomarsi, K., and A. B. Pardee. 1993. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA 90:1112-1116.
5. Schauer, I. E., S. Siriwardana, T. A. Langan, and R. A. Sclafani. 1994. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer. Proc. Natl. Acad. Sci. USA 91:7827-7831.
6. Gillett, C., V. Ranti, R. Smith, C. Fisher, J. Bartek, C. Dickson, D. Barnes, and G. Peters. 1994. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res. 54: 1812-1817.
7. Muller, D., R. Millon, R. Lidereau, A. Engelmann, G. Bronner, H. Flesh, M. Eber, G. Methlin, and J. Abecassis. 1994. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur. J. Cancer Oral Oncol. 30: 113-120.
8. Resnitzky, D., M. Gossen, H. Bujard, and S. I. Reed. 1994. Acceleration of the G1/S phase transition by expression of eyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669-1679.
9. Lukas, J., M. Pagano, Z. Staskova, G. Draetta, and J. Bartek. 1994. Cyclin D1 protein oscillates and is essential for cell cycle progression human tumor cell lines. Oncogene 9:707-718.
10. Hinds, P. W., S. F. Dowdy, E. N. Eaton, A. Arnold, and R. A. Weinberg. 1994. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA 91:709-713.
11. Lovec, H., A. Sewing, F. C. Lucibello, R. Muller, and T. Moroy. 1994. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9:323-326.
12. Xiong, Y., H. Zhang, and D. Beach. 1992. D type cyclins associate with multiple protein kinases and the DNA replicates factor PCNA. Cell 71:505-514.
13. World Health Organization. 1981. Histological Typing of Lung Tumors, 2nd ed. Geneva. 25-26; 1993, Oncogene 8:1913-1919.
14. World Health Organization. 1981. Histological Typing of Lung Tumors, 2nd ed. Geneva. 25-26; 1993, Oncogene 8:1913-1919.
15. Beahrs, O. H., D. E. Henson, R. V. P. Hutter, and B. J. Kennedy. 1992. Lung. Manual for Staging of Cancer, 4th ed. American Joint Committee on Cancer, Chicago. 115-122.
16. Smith, D. B., and K. S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
17. Frangioni, J. V., and B. G. Neel. 1993. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210:179-187.
18. Giordano, A., J. H. Lee, J. A. Schepper, C. Herrmann, E. Harlow, U. Deuschle, D. Beach, and B. R. Franza. 1991. Cell cycle regulation of histone H1 kinase activity associated with adenovirus protein E1A. Science 253:1271-1275.
19. 2 has growth suppressive properties similar to get distinctive from those of retin-oblastoma family members of φRb and φL07. Cancer Res. 54:5556-5560.
20. Cordon-Carlo, C. 1995. Mutation of cell cycle regulators. Am. J. Pathol. 147:1-16.
21. Rosenberg, C. L., E. Wong, E. M. Petty, A. E. Bale, Y. Tsujimoto, N. L. Harris, and A. Arnold. 1991. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. USA 88:9638-9642.
22. Buckley, M. F., K. J. E. Sweeney, J. A. Hamilton, R. L. Sini, D. L. Manning, R. I. Nicholson, A. DeFazio, C. K. W. Watts, E. A. Musgrove, and R. L. Sutherland. 1993. Expression and amplification of cyclin genes in human breast cancer. Oncogene 8:2127-2133.
23. DeBoer, C. J., S. Loyson, P. M. Kluin, H. C. Kluin-Nelemans, E. Schuring, and J. H. J. M. Van Krieken. 1993. Multiple breakpoints within the BcI-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. Cancer Res. 53:4148-4152.
24. Jiang, W., Y. J. Zhang, S. M. Kahn, M. C. Hollstein, R. M. Santella, S. H. Lu, C. C. Harris, R. Montesano, and I. B. Weinstein. 1993. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. Natl. Acad. Sci. USA 90:9026-9030.
25. Leach, F. S., S. J. Elledge, C. J. Sherr, J. K. V. Willson, S. Markowitz, K. W. Kinzler, and B. Vogclstein. 1993. Amplification of cyclin genes in colorectal cancer. Cancer Res. 53:1986-1989.
26. Zhang, Y. J., W. Jiang, C. J. Chen, C. S. Lee, S. M. Kahn, R. M. Santella, and I. B. Weinslein. 1993. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 196: 1010-1016.
27. Betticher, D. C., J. Heighway, P. S. Hasleton, H. J. Altermatt, W. D. J. Ryder, T. Cerny, and N. Thatcher. 1996. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small cell lung cancer. Br. J. Cancer 73:294-300.
28. Yang, W. I., K. Y. Chung, D. H. Shin, and Y. B. Kim. 1996. Cyclin D1 protein expression in lung cancer. Yonsei Med. J. 37:142-150.
29. Nihisho, M., T. Koshikawa, Y. Yatabe, T. Kuroishi, M. Suyama, M. Nagatake, T. Sugiura, Y. Ariyoshi, T. Mitsudomi, and T. Takahashi. 1997. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancer. Clin. Cancer Res. 3:1051-1058.
30. Quelle, D. E., R. A. Ashmun, S. A. Shurtleff, J. Y. Kato, D. Bar-Sagi, M. F. Roussel, and C. J. Sherr. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblast. Genes Dev. 7:1559-1671.
31. Blin, N., and D. W. Stafford. 1976. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3:2303-2308.